Abbott Laboratories
ABT130.620USD
+0.120+0.09%
收盤 04/30, 16:00（美東）報價延遲15分鐘
226.19B總市值
16.88本益比TTM
關於 Abbott Laboratories 公司
雅培實驗室是一家全球醫療保健公司。該公司從事多種多樣的醫療保健產品的發現、開發、製造和銷售。該公司通過四個部門運營：成熟醫藥產品部門、診斷產品部門、營養產品部門和醫療器械部門。成熟醫藥產品部門從事多種品牌仿製藥產品的國際銷售。診斷產品部門從事血庫、醫院、商業實驗室和替代護理檢測站的診斷系統和測試的全球銷售。營養產品部門從事多種成人和兒童營養產品的全球銷售。醫療器械部門包括節律管理、電生理學、心力衰竭、血管、結構性心臟、神經調節和糖尿病護理產品的全球銷售。
公司簡介
公司代碼ABT
公司名稱Abbott Laboratories
上市日期Mar 01, 1937
成立日期1900
CEOMr. Robert B. Ford
員工數量114000
證券類型Ordinary Share
年結日Mar 01
公司地址100 Abbott Park Road
城市ABBOTT PARK
上市交易所NYSE Consolidated
國家United States of America
郵編60064-3500
電話12246676100
網址https://www.abbott.com
公司代碼ABT
上市日期Mar 01, 1937
成立日期1900
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.88K
-1.63%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
56.91K
+44.72%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
+4.17%
Ms. Nancy Mckinstry
Ms. Nancy Mckinstry
Lead Independent Director
Lead Independent Director
38.72K
+4.41%
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
36.66K
+4.67%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.88K
-1.63%
收入明細
單位: USD更新時間: 4月6日 週日
單位: USD更新時間: 4月6日 週日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Diabetes Care
6.80B
16.22%
Core Laboratory
5.24B
12.48%
Adult Nutritionals
4.39B
10.46%
Pediatric Nutritionals
4.02B
9.59%
Key Emerging Markets
3.86B
9.20%
Other
17.64B
42.05%
地區USD
名稱
營收
佔比
United States
16.32B
38.91%
All other Countries
14.85B
35.39%
Germany
2.54B
6.05%
China
2.11B
5.04%
India
1.82B
4.33%
Other
4.31B
10.28%
業務
地區
業務USD
名稱
營收
佔比
Diabetes Care
6.80B
16.22%
Core Laboratory
5.24B
12.48%
Adult Nutritionals
4.39B
10.46%
Pediatric Nutritionals
4.02B
9.59%
Key Emerging Markets
3.86B
9.20%
Other
17.64B
42.05%
股東統計
更新時間: 2月9日 週日
更新時間: 2月9日 週日
持股股東
股東類型
持股股東
股東統計
佔比
The Vanguard Group, Inc.
9.68%
BlackRock Institutional Trust Company, N.A.
5.02%
State Street Global Advisors (US)
4.45%
Capital International Investors
3.92%
Capital Research Global Investors
3.12%
Other
73.81%
持股股東
股東統計
佔比
The Vanguard Group, Inc.
9.68%
BlackRock Institutional Trust Company, N.A.
5.02%
State Street Global Advisors (US)
4.45%
Capital International Investors
3.92%
Capital Research Global Investors
3.12%
Other
73.81%
股東類型
股東統計
佔比
Investment Advisor
35.63%
Investment Advisor/Hedge Fund
32.73%
Research Firm
3.15%
Pension Fund
2.28%
Bank and Trust
2.13%
Sovereign Wealth Fund
1.31%
Insurance Company
0.99%
Hedge Fund
0.89%
Individual Investor
0.48%
Other
20.41%
機構持股
更新時間: 1月19日 週日
更新時間: 1月19日 週日
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
4527
1.39B
80.29%
+21.54M
2024Q4
4535
1.39B
80.22%
+15.89M
2024Q3
4391
1.36B
78.29%
-11.85M
2024Q2
4400
1.36B
78.24%
-7.03M
2024Q1
4402
1.35B
77.67%
-9.71M
2023Q4
4429
1.35B
77.56%
-11.05M
2023Q3
4298
1.34B
77.39%
-25.33M
2023Q2
4297
1.35B
77.60%
-13.55M
2023Q1
4281
1.35B
77.46%
-8.61M
2022Q4
4258
1.34B
76.84%
-15.37M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
167.89M
9.68%
+762.54K
+0.46%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
87.07M
5.02%
+811.85K
+0.94%
Dec 31, 2024
State Street Global Advisors (US)
77.17M
4.45%
+447.25K
+0.58%
Dec 31, 2024
Capital International Investors
67.97M
3.92%
+2.23M
+3.39%
Dec 31, 2024
Capital Research Global Investors
54.10M
3.12%
+795.07K
+1.49%
Dec 31, 2024
Geode Capital Management, L.L.C.
35.67M
2.06%
+765.64K
+2.19%
Dec 31, 2024
Wellington Management Company, LLP
26.39M
1.52%
+581.33K
+2.25%
Dec 31, 2024
JP Morgan Asset Management
25.13M
1.45%
+5.11M
+25.51%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
20.98M
1.21%
+626.72K
+3.08%
Dec 31, 2024
Wells Fargo Advisors
15.25M
0.88%
-105.40K
-0.69%
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月5日 週六
更新時間: 4月5日 週六
機構名稱
佔比
iShares U.S. Medical Devices ETF
17.41%
Invesco Pharmaceuticals ETF
5.78%
Goldman Sachs Future Health Care Equity ETF
5.19%
NYLI Healthy Hearts ETF
4.78%
Polen Capital Global Growth ETF
4.77%
AdvisorShares Focused Equity ETF
4.63%
Proshares Ultra Health Care
4.32%
Health Care Select Sector SPDR Fund
4.24%
iShares U.S. Healthcare ETF
4.15%
Fidelity MSCI Health Care Index ETF
3.85%
查看更多
iShares U.S. Medical Devices ETF
佔比17.41%
Invesco Pharmaceuticals ETF
佔比5.78%
Goldman Sachs Future Health Care Equity ETF
佔比5.19%
NYLI Healthy Hearts ETF
佔比4.78%
Polen Capital Global Growth ETF
佔比4.77%
AdvisorShares Focused Equity ETF
佔比4.63%
Proshares Ultra Health Care
佔比4.32%
Health Care Select Sector SPDR Fund
佔比4.24%
iShares U.S. Healthcare ETF
佔比4.15%
Fidelity MSCI Health Care Index ETF
佔比3.85%
分紅派息
近5年累計派現
16.46B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Dec 13, 2024
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option
Jan 15, 2025
Feb 14, 2025
Jan 15, 2025
Sep 19, 2024
ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024
Oct 15, 2024
Nov 15, 2024
Oct 15, 2024
Jun 15, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option
Jul 15, 2024
Aug 15, 2024
Jul 15, 2024
Feb 16, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024
Apr 15, 2024
May 15, 2024
Apr 12, 2024
Dec 15, 2023
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option
Jan 12, 2024
Feb 15, 2024
Jan 11, 2024
Sep 21, 2023
ABT.NB Final Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option
Oct 13, 2023
Nov 15, 2023
Oct 12, 2023
Jun 09, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 15, 2023 going ex on Jul 13, 2023 with reinvestment option
Jul 14, 2023
Aug 15, 2023
Jul 13, 2023
Feb 17, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on May 15, 2023 going ex on Apr 13, 2023 with reinvestment option
Apr 14, 2023
May 15, 2023
Apr 13, 2023
Dec 09, 2022
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 15, 2023 going ex on Jan 12, 2023 with reinvestment option
Jan 13, 2023
Feb 15, 2023
Jan 12, 2023
Sep 15, 2022
ABT.NB Final Cash Dividend of gross USD 0.47 paid on Nov 15, 2022 going ex on Oct 13, 2022 with reinvestment option
Oct 14, 2022
Nov 15, 2022
Oct 13, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據